Naloxone in NEMT vans: whether to carry it, training drivers, and storage in a hot or cold van

Required, allowed, or off-limits: check your program first

Whether your vans should carry naloxone starts with a question most owners skip: does your program let drivers give medication at all. The answer differs by state and by contract, and it can conflict with state law.

• Colorado: training is required. The state’s NEMT rule requires every driver of an enrolled provider to be trained and certified in CPR and in giving naloxone (10 CCR 2505-10, section 8.014.3.B.8.f). Rideshare companies with a state utilities commission permit are exempt from that part of the rule and follow the commission’s requirements. The rule covers training. It does not say each van must carry a kit, so a Colorado company still writes its own stocking policy.
• Virginia: state law allows it, the member manual bars drivers from giving medication. Virginia law lets any person give naloxone to someone believed to be having a life-threatening opioid overdose (Va. Code 54.1-3408, subsection AA), and a person who does so in good faith is shielded from civil damages unless the act was grossly negligent or willful and wanton misconduct (Va. Code 8.01-225(A)(21)). The state’s Medicaid NEMT member manual, dated June 2026, tells members that drivers cannot handle or give medications or help with oxygen unless the trip is by ambulance. A Virginia provider should get the broker’s answer in writing before putting naloxone in its vans.
• Everywhere else: your contract and your state. Every state and the District of Columbia had enacted a naloxone access law by July 1, 2017, though the protection each one gives varies. CDC notes that most states also have Good Samaritan laws that protect a person who is overdosing, and anyone helping them in an emergency, from criminal penalties.

If a broker contract is silent, ask the broker. A written yes protects the driver and the company. A written no saves you from training drivers on something they are not allowed to do.

What over-the-counter naloxone is

Naloxone reverses an opioid overdose by restoring breathing, and the nasal spray can be bought without a prescription. FDA approved Narcan 4 mg nasal spray for over-the-counter sale on March 29, 2023, the first naloxone product approved for use without a prescription, and said generic 4 mg sprays based on it would have to switch to over-the-counter labels too. RiVive 3 mg became the second over-the-counter product on July 28, 2023. CDC says naloxone is available over the counter in all 50 states and that anyone can carry and give it without medical training.

A few facts from the federal guidance shape how drivers should think about it:

• It works on fentanyl. SAMHSA’s toolkit says overdose reversal medications work on fentanyl overdoses, and CDC notes that strong opioids like fentanyl may take more than one dose. SAMHSA adds that giving doses faster does not speed up the reversal, so the two to three minute wait between doses still applies.
• It can be less effective with other sedatives. The toolkit names alcohol, benzodiazepines, and xylazine as drugs that can make a reversal harder.
• It wears off. The prescription label warns that overdose signs can return after a dose, which is why the person must be watched until emergency help arrives.
• It does not harm someone who is not on opioids. CDC says it will not harm a person overdosing on other drugs.

The over-the-counter label’s steps fit on a card: check for an overdose (the person will not wake up, is very sleepy, or is not breathing well), give the first dose in one nostril, call 911, keep giving a dose every two to three minutes until the person wakes, and stay until the ambulance arrives, giving another dose if the person becomes very sleepy again. The prescription patient information adds that rescue breathing or CPR may be given while waiting for help.

Heat, cold, and a parked van

Storage is where van policies go wrong, because the labels set different limits and a parked van can exceed all of them. Here is what each label says.

Heat is the main risk in summer. The National Weather Service has shown a closed car going from a safe temperature to 94.3°F in just over two minutes, and notes that a dark dashboard or seat can reach 180°F to more than 200°F in the sun. A glovebox, door pocket, or dashboard tray in a van parked outside a dialysis center in July is the wrong place for a kit labeled to stay under 104°F.

Cold matters in northern winters. The prescription Narcan label says the spray freezes below 5°F, and a frozen device will not spray. It also says the device can be thawed by leaving it at room temperature for about 15 minutes and can still be used after thawing, but that no one should wait for it to thaw in an emergency. The first move is calling 911. RiVive’s label adds a different limit: do not refrigerate it at all.

The chemistry may be tougher than the labels. A 2019 study in the Harm Reduction Journal exposed naloxone ampoules to 80°C (176°F) for eight hours a day, and separately to repeated freezing and thawing, for 28 days, and found no loss of naloxone. The study tested injectable ampoules, not nasal spray devices, and its authors still stressed proper storage. Treat it as a reason not to panic over a kit that got warm once, not as permission to store kits in the dash.

Practical options that keep a kit inside its label range:

• Driver carries it. The kit goes in a jacket pocket or a small bag that travels with the driver and comes inside at the end of the shift.
• Insulated pouch in the cabin. It stays out of direct sun, away from the dash, and comes indoors overnight in freezing weather.
• Office stock. Kits live indoors at the base and are signed out with the van keys each morning.

Training drivers to use it

A kit no one is trained on is a liability, and in Colorado it is also a rule violation. Training for NEMT drivers should cover:

1. Recognizing an overdose. The prescription label lists unusual sleepiness with no response to a loud voice or a firm rub on the breastbone, slow or shallow breathing, and very small pupils in someone hard to wake.
2. Stopping the van safely. Nothing happens until the vehicle is pulled over and in park.
3. Giving the dose and calling 911. Follow the label’s order, and have dispatch call 911 and stay on the line if the driver’s hands are full.
4. Repeat doses and waiting. Two to three minutes between doses, and staying with the rider until help arrives even if they wake up.
5. What waking up looks like. The label warns of shaking, sweating, nausea, or anger. A driver who expects it can keep the rider calm and seated.
6. Breathing support. Rescue breathing or CPR while waiting, within the driver’s CPR training. See CPR and first aid for NEMT drivers for course options.

SAMHSA’s toolkit is free and written for the general public, which makes it a good base for an in-house session. Keep a record of who was trained and when, and in Colorado keep each driver’s certification on file with their other credentials.

Writing the van policy

A one-page policy keeps every driver on the same rules. Cover these points:

• Which vans carry it. Every vehicle, only vehicles on certain routes, or only supervisors. One option is to start with vans on routes to clinics where riders are more likely to use opioids, such as the daily dosing trips described in opioid treatment program rides.
• Who may give it. Trained drivers only, and only where the program allows.
• Where it lives. One of the storage options above, written down, so a driver never has to hunt.
• How it is checked. Expiration date and an intact blister pack, checked on a set schedule such as the first shift of each month. The over-the-counter label says not to use a device if its blister is open or torn.
• After a use. Replace the kit the same day, write an incident report, and tell the broker on the contract’s timeline. Modivcare’s 2025 attestation requires immediate notice of any incident on its trips, and Louisiana Medicaid requires a written report within 72 hours when a beneficiary is injured or dies in the provider’s care.
• Privacy. Describe the event in the report and leave guesses about the rider’s drug use out of chat messages and texts.

The incident report template has room for the times, the doses given, and who was called. Our guide to a medical emergency during a ride covers the rest of the 911 decision.

When the rider carries their own

Some riders who use opioids, or their families, carry their own naloxone. That is their medication. Virginia’s member manual, for one, makes medications part of the personal items members are responsible for. The prescription Narcan patient information says family members and caregivers should know where the spray is kept and how to use it before an emergency.

For a driver, the practical point is simple. If a rider’s companion or the rider’s own kit is there during an overdose, the companion can give it while the driver pulls over and calls 911. Whether the driver may use the rider’s kit comes back to the same program rules as a company kit.

Keeping drivers informed

A naloxone policy only works if every driver has read it. HealthRide’s team chat sends announcements with read receipts, so you can see who has opened the storage rule before the first heat wave. In Colorado, add the naloxone certification to each driver’s credentials on the fleet page, and HealthRide sends a reminder before it runs out and flags any assignment to a driver whose card has lapsed.